PHILADELPHIA — Advancing telemedicine screening protocols may be key in the future of diagnosing and treating diabetic retinopathy and age-related macular degeneration, according to a speaker. At the Wills Vision Research Center at Jefferson annual symposium, S.K. Steven Houston III, MD, discussed advances in telemedicine technology at Wills Eye Hospital.
LOS ANGELES–(BUSINESS WIRE)–The Petersen Foundation is giving $2.5 million to support The Vision Center at Children’s Hospital Los Angeles in efforts to advance education, research and telehealth technology.
NICE, France — Intravitreal sirolimus provides long-term resolution of posterior segment inflammation in patients with active noninfectious uveitis, according to the 1-year results of the SAKURA study. “[Noninfectious uveitis] of the posterior segment is in the vast majority of cases a chronic condition, requiring long-term treatment to prevent cumulative structural damage and vision loss,” Phuc Hoang, MD, PhD, said at the Euretina meeting.
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will be attending the 19th Annual Australasian Society of Cataract and Refractive Surgeons (AUSCRS) Conference being held from Octob…
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops first-in-class drug therapies to treat diseases of the eye, announces enrollment of 50th patient using suprachoroidal (SCS™) drug administration.
IRVINE, Calif. & EMERYVILLE, Calif.–(BUSINESS WIRE)–ALPHAEON Corporation and NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY) announced today that they have formed a partnership that will add NovaBay’s breakthrough Avenova™ to the products that ALPHAEON makes available to patients and doctors. Under terms of the agreement, Avenova will now be available for purchase on the ShoutMD® Store, the first social commerce store for lifestyle healthcare products. On ShoutMD, member physicians will now be